Word

OLUMIANT

Status

Dead

Status Code

606

Status Date

Monday, November 5, 2018

Serial Number

86827301

Mark Type

3000

Filing Date

Friday, November 20, 2015

Published for Opposition

Tuesday, February 9, 2016

Abandoned Date

Monday, November 5, 2018

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

44 Medical information services in the field of autoimmune diseases and disorders

Color is not claimed as a feature of the mark.
The mark consists of literal element "Olumiant" with five rows of juxtaposed squares forming rays or shafts of light positioned next to the "t".

Trademark Events

Nov 5, 2018

Abandonment Notice Mailed - No Use Statement Filed

Nov 5, 2018

Abandonment - No Use Statement Filed

Mar 29, 2018

Notice Of Approval Of Extension Request E-Mailed

Mar 27, 2018

Extension 4 Granted

Mar 27, 2018

Extension 4 Filed

Mar 27, 2018

Teas Extension Received

Sep 19, 2017

Notice Of Approval Of Extension Request E-Mailed

Sep 15, 2017

Extension 3 Granted

Sep 15, 2017

Extension 3 Filed

Sep 15, 2017

Teas Extension Received

May 13, 2017

Notice Of Approval Of Extension Request E-Mailed

May 12, 2017

Extension 2 Granted

Mar 31, 2017

Extension 2 Filed

Mar 31, 2017

Teas Extension Received

Mar 9, 2017

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 9, 2017

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 8, 2016

Notice Of Approval Of Extension Request E-Mailed

Nov 7, 2016

Extension 1 Granted

Sep 23, 2016

Extension 1 Filed

Oct 15, 2016

Case Assigned To Intent To Use Paralegal

Sep 23, 2016

Teas Extension Received

Apr 5, 2016

Noa E-Mailed - Sou Required From Applicant

Feb 9, 2016

Official Gazette Publication Confirmation E-Mailed

Feb 9, 2016

Published For Opposition

Jan 20, 2016

Notification Of Notice Of Publication E-Mailed

Dec 28, 2015

Approved For Pub - Principal Register

Dec 28, 2015

Assigned To Examiner

Nov 26, 2015

Notice Of Design Search Code E-Mailed

Nov 25, 2015

New Application Office Supplied Data Entered In Tram

Nov 24, 2015

New Application Entered In Tram